Assuming a positive antibiotic phase 2a, then the company has two options available to it. Firstly to proceed with phase 2b rosacea, which as we know is an absolute given. Reason being, the success of that is a pre requisite for the big phase 3 acne. Secondly, they could do a phase 2b in the antibiotic platform and this to me is a given. Raising some more cash is also a given considering they will probably do both.
Hence the urgency of having success in the near future for the antibiotic platform.
Hold onto your horses as we know sometimes they throw in a curve ball.
Ann: Results of Meeting, page-5
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $725.6M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 41.0¢ | 39.5¢ | $2.436M | 6.081M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 185492 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 10290 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |